Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
The White House released a 30-page white paper Friday morning that promotes easing government regulations and spurring innovation to lower drug prices, while roundly rejecting the idea of government price setting.
Donald Trump’s health-care chief said he plans to take up the president’s promises to do something about pharmaceutical prices, targeting some of the U.S.’s costliest drugs with proposals to reduce patients’ out-of-pocket spending.
It's hard to overshadow an industry-defining $67 billion merger of a drug-store mega-chain and large health insurer.
Senate leaders announced on Wednesday that, as part of a broader budget agreement, they would lengthen the six-year funding extension for CHIP that Congress passed last month to a full 10 years of funding for the program. After a brief government shutdown on Friday morning, Congress passed that deal into law.
Murray, who is leading negotiations for Senate Democrats on the issue, wants to increase the ObamaCare tax credits that help people afford coverage, according to a Senate Democratic aide. That would be a significant expansion of ObamaCare that could help make premiums more affordable for many people.
President Donald Trump delivered his first State of the Union Address on Tuesday, and now NAHU invites you to join us next week as Executive Vice President and CEO Janet Trautwein hosts a special edition of the LIVE from NAHU webinar series titled "State of the Union...and Health Policy" at 9 am , Pacific time, on Thursday, February 8.
It was expected to be a perfunctory statehouse meeting — three lobbyists and a legislator discussing a proposal to educate Louisiana doctors about the price of drugs they prescribe.
Amazon, Berkshire Hathaway and JPMorgan Chase announced on Tuesday that they would form an independent health care company for their employees in the United States.
President Trump used the swearing-in of the new secretary of health and human services as an opportunity to decry high prescription drug prices and pledge to bring them down — an intention he has long trumpeted but on which he has yet to follow through.
With his confirmation last week, Alex Azar officially took the reins at HHS. During his confirmation hearings, Azar addressed four key priorities for the department: